Related Experiment Video
Updated: Jul 16, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Migration of the left atrial appendage closure device to the aorta
Susana González-Suárez1, José Carlos Sureda Barbosa2, María Sol Siliato Robles2
1Department of Surgery, Department of Anesthesiology and Intensive Care, Cardiovascular diseases Research Group, Universitat Autònoma de Barcelona, Unitat Docent Vall d´Hebron, Vall d´Hebron University Hospital, Vall d´Hebron Institut de Recerca (VHIR), Passeig Vall d´Hebron 119-129, Barcelona, 08035, Spain. susana.gonzalez@uab.cat.
Insights
Left atrial appendage closure is an alternative to anticoagulation but can cause complications. Device migration led to severe aortic insufficiency, necessitating emergency cardiac surgery for removal.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Left atrial appendage (LAA) closure offers an alternative to long-term anticoagulation for patients with atrial fibrillation and contraindications to blood thinners, such as recurrent bleeding.
- Percutaneous LAA closure devices aim to prevent stroke by sealing the LAA, a common source of emboli.
Observation:
- A patient requiring LAA closure due to contraindications for anticoagulation therapy developed severe aortic insufficiency.
- The complication was directly attributed to the migration of the implanted LAA closure device.
Findings:
- Device migration is a rare but serious complication of percutaneous LAA closure.
- Severe aortic insufficiency resulted from the displaced LAA closure device, posing an immediate threat to the patient's life.
Implications:
- This case highlights the potential risks associated with LAA closure devices and the need for careful patient selection and monitoring.
- Urgent surgical intervention may be required to manage device-related complications, emphasizing the importance of a multidisciplinary approach in managing atrial fibrillation patients.
- Further research into device design and implantation techniques may be warranted to minimize migration risks.
Abstract:
Percutaneous closure of the left atrial appendage may be indicated in patients with contraindications to anticoagulation therapy, for example, after recurrent gastrointestinal bleeding. It is an effective and safe procedure but is not without complications. We present a patient who presented with severe aortic insufficiency due to migration of the left atrial appendage closure device, which required urgent cardiac surgery for its removal.
Related Concept Videos
Location and Orientation of the Heart
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Aortic Regurgitation III: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

